Chronic liver disease: Systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients

Radiology

Volumn 261, Issue 1, 2011, Pages 144-155

  Gouya, Hervé ^a   Vignaux, Olivier ^a   Sogni, Philippe ^b   Mallet, Vincent ^b   Oudjit, Ammar ^a   Pol, Stanislas ^b   Legmann, Paul ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA; ADULT; AGED; AORTA FLOW; ARTICLE; AZYGOS VEIN; BLOOD FLOWMETRY; CHRONIC LIVER DISEASE; CINE PHASE CONTRAST NUCLEAR MAGNETIC RESONANCE IMAGING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PHANTOM; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SPLANCHNIC BLOOD FLOW; SYSTEMIC CIRCULATION; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; AZYGOS VEIN; CHRONIC DISEASE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PHANTOMS, IMAGING; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; SPLANCHNIC CIRCULATION;

EID: 80053075580     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101541     Document Type: Article

References (30)

1. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46(3):922-938. (Pubitemid 47436138)
2. Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodés J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis: clinical and haemodynamic correlations in 100 patients. J Hepatol 1985;1(2):125-139. (Pubitemid 15038042)
3. Sukigara M, Shimoji K, Ohata M, et al. Effects of propranolol and nitroglycerin on cephalad collateral venous flow in patients with cirrhosis: evaluation using transesophageal real-time two-dimensional Doppler echography. Am J Gastroenterol 1988;83(11):1248-1254.
4. Pelc LR, Pelc NJ, Rayhill SC, et al. Arterial and venous blood flow: noninvasive quanti tation with MR imaging. Radiology 1992;185(3):809-812.
5. Sanz J, Kuschnir P, Rius T, et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007;243(1):70-79. (Pubitemid 46579696)
6. Nabeshima M, Moriyasu F, Nishikawa K, et al. Azygos venous blood flow: measurement with direct bolus imaging. Radiology 1995;195(2):467-470.
7. Wu MT, Pan HB, Chen C, et al. Azygos blood flow in cirrhosis: measurement with MR imaging and correlation with variceal hemorrhage. Radiology 1996;198(2):457-462. (Pubitemid 26036854)
8. Debatin JF, Zahner B, Meyenberger C, et al. Azygos blood flow: phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement. Hepatology 1996;24(5):1109-1115. (Pubitemid 26365912)
9. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C: The METAVIR Cooperative Study Group. Hepatology 1996;24(2):289-293. (Pubitemid 26260021)
10. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ 1996;313(7048):41-42. (Pubitemid 26229891)
11. Korn EL. Sample size tables for bounding small proportions. Biometrics 1986;42(1):213-216.
12. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44(3):837-845.
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174. (Pubitemid 8054849)
14. Pagliaro L, D'Amico G, Pasta L, et al. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann RJ, eds. Portal hypertension: pathophysiology and treatment. Oxford, England: Blackwell Scientific, 1994;72-92.
15. Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128(2):343-350. (Pubitemid 40439195)
16. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38(2):518-526. (Pubitemid 36919874)
17. D'Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology 2004;39(1):30-34. (Pubitemid 38461462)
18. Matsuo M, Kanematsu M, Kim T, et al. Esophageal varices: diagnosis with gadolinium-enhanced MR imaging of the liver for patients with chronic liver damage. AJR Am J Roentgenol 2003;180(2):461-466. (Pubitemid 36135032)
19. Kim YJ, Raman SS, Yu NC, To'o KJ, Jutabha R, Lu DS. Esophageal varices in cirrhotic patients: evaluation with liver CT. AJR Am J Roentgenol 2007;188(1):139-144. (Pubitemid 46012500)
20. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988;319(15):983-989.
21. Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis 2008;28(1):110-122. (Pubitemid 351326537)
22. Moreno AH, Burchell AR, Rousselot LM, Panke WF, Slafsky F, Burke JH. Portal blood flow in cirrhosis of the liver. J Clin Invest 1967;46(3):436-445.
23. Okazaki K, Miyazaki M, Onishi S, Ito K. Effects of food intake and various extrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed Doppler with the Octoson. Scand J Gastroenterol 1986;21(9):1029-1038. (Pubitemid 17179088)
24. Ohnishi K, Sato S, Pugliese D, Tsunoda T, Saito M, Okuda K. Changes of splanchnic circulation with progression of chronic liver disease studied by echo-Doppler flowmetry. Am J Gastroenterol 1987;82(6):507-511. (Pubitemid 17086874)
25. Ronot M, Asselah T, Paradis V, et al. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology 2010;256(1):135-142.
26. Benoit JN, Womack WA, Hernandez L, Granger DN. "Forward" and "backward" flow mechanisms of portal hypertension: relative contributions in the rat model of portal vein stenosis. Gastroenterology 1985;89(5):1092-1096. (Pubitemid 16231575)
27. Sugano S, Yamamoto K, Sasao K, Watanabe M. Portal venous blood flow while breath-holding after inspiration or expiration and during normal respiration in controls and cirrhotics. J Gastroenterol 1999;34(5):613-618. (Pubitemid 29500326)
28. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47(6):1202-1210. (Pubitemid 34587412)
29. Lomas DJ, Hayball MP, Jones DP, Sims C, Allison ME, Alexander GJ. Non-invasive measurement of azygos venous blood flow using magnetic resonance. J Hepatol 1995;22(4):399-403.
30. Ng WH, Chan YL, Sung JY, Lee YT, Lee SF, Chung SS. Comparison of breath-hold 2D phase-contrast with non breath-hold cine phase-contrast MRA in the assessment of azygos venous blood flow in portal hypertension. MAGMA 2004;16(5):211-217. (Pubitemid 39186270)